Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2002

Peraud Aurelia, Kreth Friedrich W, Wiestler Otmar D, Kleihues Paul, Reulen Hans-Jürgen

Abstract excerpt

PURPOSE: The purpose of this study was to analyze retrospectively timing, frequency, and prognostic impact of TP53 mutations and P53 protein accumulation in supratentorial WHO grade II astrocytomas and oligoastrocytomas of adult patients. EXPERIMENTAL DESIGN: We included 159 consecutively treated patients (1991-1998), and each tumor was screened for TP53 mutations and P53 protein overexpression. Prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Immunohistochemistry

Share to Polymorphism, Single-Stranded Conformational

Share to Severity of Illness Index

Share to Tumor Suppressor Protein p53

Share to World Health Organization

Source

Identifiers

PMID: 12006527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.PMID 12006527Read ↗

Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.Semantic proximity Read ↗

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.Semantic proximity Read ↗

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.Semantic proximity Read ↗

TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.Semantic proximity Read ↗

Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatmentSemantic proximity Read ↗

Supratentorial grade II astrocytoma: biological features and clinical course.Semantic proximity Read ↗

Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.Semantic proximity Read ↗

Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas.Semantic proximity Read ↗

p53 mutations in nonastrocytic human brain tumors.Semantic proximity Read ↗

TP53 gene mutations and 17p deletions in human astrocytomas.Semantic proximity Read ↗

Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.Semantic proximity Read ↗

Genotype-phenotype correlation in gemistocytic astrocytomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.